The Claim
Myostatin, a myokine produced in skeletal muscle, acts as a negative regulator of muscle growth, and elevated myostatin levels are associated with muscle atrophy, indicating that inhibition of myostatin may represent a therapeutic strategy for muscular dystrophy.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Myostatin is a protein made in muscle that limits muscle growth; higher levels of this protein are linked to muscle wasting, and blocking it could treat muscular dystrophy.
See the scientific wording
Myostatin is a myokine produced in skeletal muscle that functions as a negative regulator of muscle growth, and elevated levels are associated with muscle atrophy, suggesting its inhibition could be a therapeutic strategy for conditions like muscular dystrophy.
A protein that stops muscles from growing is kept inactive by a specific part of its structure. When a molecule binds to that part, it prevents the protein from becoming active. Without the active protein, muscles receive signals to build more protein and get bigger.
What the research says
1 studyStudy: Exploring the Myostatin Activation Pathway: A Promising Target for Treating Muscle Atrophy
This study shows that blocking a protein called myostatin—which stops muscles from growing—could help people with muscle-wasting diseases. It found new ways to turn off this protein, which might lead to better treatments.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.